Incyte lists 10 executives, led by William J. Meury, CEO & Director (age 57). Suketu P. Upadhyay is the company's Executive VP & CFO (age 56).
In fiscal year 2025 the highest-paid executive was Mohamed Khairie Issa, Executive Vice President & Head of U.S. Commercial, with total pay of $2.27 million. The 5 executives with reported pay received $8.44 million in all.
The average age of the executives with a known age is 58; the youngest is 42 and the oldest 74.
Titles, ages and pay from company filings; pay for fiscal year 2025.

CEO & Director
President and Global Head of R&D
Principal Financial Officer, VP of Finance & Chief Accounting Officer
Executive VP, Head of Late-stage Development & Chief Medical Officer
Executive Vice President & Head of U.S. Commercial
Executive VP & CFO
Executive VP & Head of Global Technical Operations
VP & Head of Investor Relations
Executive VP, General Counsel & Secretary
VP of Investor Relations & Corporate Communications
| Executive | Title | Age | Total pay |
|---|---|---|---|
| Mohamed Khairie Issa | Executive Vice President & Head of U.S. Commercial | 42 | $2.27 million |
| Pablo J. Cagnoni M.D., Ph.D. | President and Global Head of R&D | 62 | $2.07 million |
| William J. Meury | CEO & Director | 57 | $2.00 million |
| Steven H. Stein M.D. | Executive VP, Head of Late-stage Development & Chief Medical Officer | 58 | $1.57 million |
| Thomas Tray | Principal Financial Officer, VP of Finance & Chief Accounting Officer | 47 | $529,848 |
Total pay as reported for the fiscal year; it can include salary, bonus and stock awards.
William J. Meury (CEO & Director), age 57; total pay in fiscal year 2025 was $2.00 million.
Suketu P. Upadhyay (Executive VP & CFO), age 56.
Mohamed Khairie Issa, Executive Vice President & Head of U.S. Commercial, with total pay of $2.27 million in fiscal year 2025.
William J. Meury (CEO & Director), Pablo J. Cagnoni M.D., Ph.D. (President and Global Head of R&D), Thomas Tray (Principal Financial Officer, VP of Finance & Chief Accounting Officer), Steven H. Stein M.D. (Executive VP, Head of Late-stage Development & Chief Medical Officer) and Mohamed Khairie Issa (Executive Vice President & Head of U.S. Commercial), and 5 more.